June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Jarushka Naidoo: Phase III trial methylphenidate versus placebo for cancer fatigue in advanced solid tumors
May 21, 2024, 12:01

Jarushka Naidoo: Phase III trial methylphenidate versus placebo for cancer fatigue in advanced solid tumors

Jarushka Naidoo shared on X/Twitter:

“Phase III trial methylphenidate versus placebo for cancer fatigue in advanced solid tumors on Journal of Clinical Oncology.

– 162 patients, 14% NSCLC
– MPD dose, max 20mg tds
– no diff primary endpoint (FACIT-F), or QOL at 6weeks.”

Visit the article website.
Source: Jarushka Naidoo/X

Dr. Jarushka Naidoo is a thoracic oncologist at the Beaumont Hospital Dublin (Ireland), Professor in RCSI and Adjunct Professor of Oncology at Johns Hopkins University. She currently serves as national lung cancer lead for Cancer Trials Ireland. She serves on several international guideline panels including ASCO and SITC (Society of Immunotherapy for Cancer), and is an experienced clinical trialist- having developed and completed several investigator-initiated, industry-funded and cooperative group clinical trials.

She has received a number of grants including a young investigator award from the International Association for the Study of Lung Cancer (IASLC), Lung Cancer Foundation of America (LCFA), and a career development award from the National Institutes of Health (NIH) KL2-program. She is the IASLC Communications Committee Chair.